InvestorsHub Logo
Followers 36
Posts 1266
Boards Moderated 0
Alias Born 05/17/2011

Re: someconcerns post# 3220

Tuesday, 04/29/2014 5:37:14 PM

Tuesday, April 29, 2014 5:37:14 PM

Post# of 8439
The effect doesn't diminish over time. The Copaxone starts working.

No way the results could be interpreted to be bad without additional data. As an add-on to Copaxone on, it has great benefit.

In fact, from UCLA's site -- it all sounds very, very good.

http://newsroom.ucla.edu/releases/preliminary-clinical-trial-shows-great-promise-for-new-multiple-sclerosis-treatment

Folks are forgetting about its cognition benefits -- the NEUROPROTECTIVE benefits as well as the REPARATIVE benefits.

Sure, copaxone helps control relapses. But Trimesta helps 1) control them better, 2) starts working FASTER and 3)might reverse damage already caused by the disease.

Knock, knock who's there? Oh Teva, it's you!

:)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News